2024 achievements

MLM Medtech proudly reflects on its achievements in its first year since its founding on December 16, 2023.

• Empowering Diabetes Care with "oder.expert"

Leveraging our expertise in Direct-to-Patient (DTP) delivery, we contributed to the order.expert platform, enabling Austrians with diabetes to manage their lifesaving product deliveries more efficiently. Developed by opta data’s skilled software engineers under Scrum methodology, the platform launched an MVP for LifeScan patients in September. Upcoming expansions will target commercial offerings to statutory health insurances and manufacturers for sustainable DTP services.

• Pioneering Renal Denervation Therapy

The launch of Recor’s Paradise™ System, an ultrasound-based renal denervation (uRDN) therapy, has achieved reimbursement approval starting January 1, 2025. In October, Klinikum Wels signed the first commercial agreement. This groundbreaking therapy for medically resistant hypertension is gaining attention among internists. MLM has initiated a therapy awareness campaign and is preparing catheter lab in-services for scaling adoption.

• Reintroducing Embecta Insulin Pen Needles

Embecta’s BD-branded insulin pen needles were listed with new codes in Austria on June 1, 2024. MLM is driving full market reentry by engaging four freelance representatives for product promotion and planning to hire a new team member for the Vienna area. Meditrax serves as the logistical hub for this highly efficient demand-generation initiative. Stay tuned for our upcoming job posting!

• Market Analysis in Medical Nutrition

A detailed market analysis revealed key dynamics in Austria’s Oral Nutrition Supplements (ONS) and Enteral Nutrients (EN) sectors. MLM is poised to generate demand for the market entry of a leading medical nutrition brand.

• Expanding Opportunities in Cardiac Electrophysiology

Danish Eir Medical has partnered with MLM to assess the Austrian market potential for Synapticmedical steerable catheters used for transeptal access during cardiac electrophysiology procedures in the left atrium. Together, we will host a tech suite at the EHRA 2025 congress in Vienna.

Contact us for your demand-generation needs in diabetes and cardiology.

Happy New Year!

Martin & Team